
Pharmacology News
by Circle Of Insight Productions
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 2 chart positions in 2 markets.
By chart position
- 🇯🇵JP · Medicine#1831K to 10K
- 🇵🇱PL · Medicine#4210K to 30K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
5.5K to 20K🎙 Weekly cadence·416 episodes·Last published 2mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
11K to 40K🇵🇱75%🇯🇵25% - Active Followers
Loyal subscribers who consistently listen
3.3K to 12K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 24 epsHost
Recent guests
No guests detected in recent episodes.
Recent episodes
Psychopharmacology Masterclass: Drug Classes, Mechanisms of Action, and What Every Psychologist Needs to Know for Clinical Practice and the
Jun 24, 2026
17m 12s
Retracted: The Hepatitis B Vaccine, Autism Claims, and the Challenges of Causation
Jun 9, 2026
7m 00s
Escitalopram for Kids’ Anxiety: FDA Approval or Risky Gamble? Weighing the Evidence”
Jun 8, 2026
7m 53s
Noribogaine (DMX-1001): A Neuroplastogen Breakthrough for Alcohol Use Disorder or Another Psychedelic Promise with Risks?
Jun 1, 2026
5m 22s
Rising Costs in Healthcare: The 2026 Pharmaceutical Price Increases and Their Implications
May 27, 2026
4m 47s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/24/26 | psychopharmacologydrug classes+5 | — | SSRIsSNRIs+8 | — | psychopharmacologyantidepressants+7 | — | 17m 12s | ||
| 6/9/26 | Hepatitis B VaccineAutism+4 | — | Circle Of Insight Productions | — | Hepatitis Bvaccine+5 | — | 7m 00s | ||
| 6/8/26 | pediatric anxiety treatmentFDA approval+4 | — | escitalopramLexapro+2 | — | escitalopramLexapro+8 | — | 7m 53s | ||
| 6/1/26 | neuroplasticityalcohol use disorder+4 | — | noribogaineDMX-1001+3 | — | noribogaineDMX-1001+6 | — | 5m 22s | ||
| 5/27/26 | healthcare costspharmaceutical pricing+4 | — | IbranceComirnaty+1 | — | pharmaceuticalshealthcare+6 | — | 4m 47s | ||
| 5/26/26 | psychopharmacologymental illness+4 | — | chlorpromazineimipramine+2 | — | chlorpromazineimipramine+5 | — | 4m 30s | ||
| 5/25/26 | psychopharmacologymental illness+4 | — | chlorpromazineimipramine+2 | — | chlorpromazineimipramine+5 | — | 3m 48s | ||
| 5/21/26 | curcuminturmeric+4 | — | CurcuminTurmeric | prediabetestype 2 diabetes+2 | curcuminturmeric+7 | — | 6m 29s | ||
| 5/20/26 | OCD treatmentdextromethorphan+4 | — | dextromethorphanYale-Brown Obsessive Compulsive Scale | Iran | dextromethorphanOCD+5 | — | 7m 16s | ||
| 5/15/26 | antidepressantssuicide prevention+4 | — | SSRI | South Korea | antidepressantssuicide+5 | — | 7m 32s | ||
| 5/5/26 | medicationsfalls+4 | — | Circle Of Insight Productions | — | medicationsfalls+5 | — | 5m 07s | ||
| 5/3/26 | Emergency MedicineClinical Markers+5 | — | Circle Of Insight ProductionsThe Dangerous Tetrad: Mastering the Fatal Signs of Rigidity and Fever -case study | — | Dangerous Tetradrigidity+7 | — | 5m 21s | ||
| 4/27/26 | antidepressant withdrawalSSRIs+4 | — | JAMA Psychiatry | — | antidepressant withdrawalSSRIs+5 | — | 10m 19s | ||
| 4/26/26 | pharmacologymuscle loss+4 | — | GLP-1 receptor agonistssemaglutide+3 | — | GLP-1muscle loss+5 | — | 4m 46s | ||
| 4/20/26 | ibogainepsychedelic treatment+6 | — | — | — | addiction sciencemental health+2 | — | 7m 24s | ||
| 4/20/26 | methamphetamineneuroprotection+2 | — | — | — | low-doseneuroprotection+2 | — | 3m 10s | ||
| 4/19/26 | antidepressantsdepression+2 | — | — | — | placebo responsepublication bias+3 | — | 9m 05s | ||
| 4/11/26 | ADHDmedication+2 | — | ADHD medication | — | ADHD medicationgenetic factors+2 | — | 1m 38s | ||
| 1/6/26 | artificial intelligencemedications+2 | — | — | Utah | AIprescription+1 | — | 1m 33s | ||
| 10/19/25 | Marijuanaemphysema+2 | — | — | — | cannabislung health+1 | — | 1m 40s | ||
| 9/28/25 | ketamineneurotoxicity+2 | — | — | — | ketamineneurotoxicity+2 | — | 2m 08s | ||
| 9/14/25 | lithiummental health+2 | — | — | — | studymedication+2 | — | 1m 55s | ||
| 8/24/25 | quetiapineinsomnia+1 | — | quetiapine | — | low-dosesleep disorders+1 | — | 1m 29s | ||
| 8/17/25 | antidepressantsassessments+1 | — | — | — | prescriptionmental health assessment+1 | — | 1m 28s |
Showing 24 of 24
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Similar Audience Demographics
Podcasts that attract a similar listener profile
Chart history for Pharmacology News
Peaked at #42 in PL, currently #42 in PL.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| PL | — | #42 | #42 | — |
| Japan | — | #183 | #183 | — |
Chart Positions
2 placements across 2 markets.
Chart Positions
2 placements across 2 markets.